Radiopharma Dose Varies Globally for Pediatric Exams

New Report in Journal of Nuclear Medicine

While there are guidelines for recommended radiopharmaceutical doses for pediatric nuclear medicine patients, there is still wide variability around the world in terms of how those standards are followed, according to a new report published online March 31 in the Journal of Nuclear Medicine.

Nuclear medicine practices located in regions with such recommendations for certain procedures, such as North American, Europe, and Japan, tend to closely comply with those guidelines, “although some wide variations still exist,” concluded the Nuclear Medicine Global Initiative.

That lack of compliance, even in a few cases, can lead to the risk of a potential adverse event from ionizing radiation at certain dose levels.

Read the full article here.